A Retrospective Cohort Study Using Health Administrative Claims Databases to Assess Adverse Pregnancy and Infant Outcomes in Women with Psoriasis Who Were Exposed to Guselkumab Versus Other Biologic Therapies During Pregnancy. PASS-EMA

08/08/2019
12/01/2026
EU PAS number:
EUPAS30740
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information